UKMLA PLAB AMC USMLE Prometric MCQ

Question Number 1142
Question:
A patient with hypertriglyceridemia is considered as a high risk for premature development of coronary artery disease. He is likely to be treated with a drug that inhibits

a) hydroxy-3-methylglutaryl coenzyme A reductase
b) AMP-activated protein kinase
c) chenodeoxycholic acid
d) paroxonase
e) platelet-activating acetylhydrolase